0000711377-17-000010.txt : 20170523
0000711377-17-000010.hdr.sgml : 20170523
20170523153521
ACCESSION NUMBER: 0000711377-17-000010
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170519
FILED AS OF DATE: 20170523
DATE AS OF CHANGE: 20170523
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGEN CORP
CENTRAL INDEX KEY: 0000711377
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 382367843
STATE OF INCORPORATION: MI
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 620 LESHER PLACE
CITY: LANSING
STATE: MI
ZIP: 48912
BUSINESS PHONE: 5173729200
MAIL ADDRESS:
STREET 1: 620 LESHER PLACE
CITY: LANSING
STATE: MI
ZIP: 48912
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRADLEY EDWARD
CENTRAL INDEX KEY: 0001189021
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17988
FILM NUMBER: 17863651
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-05-19
0
0000711377
NEOGEN CORP
NEOG
0001189021
BRADLEY EDWARD
0
1
0
0
vice President
Common Stock
2017-05-19
4
S
0
5000
61.3317
D
96512
D
These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2017
Steven J Quinlan (Attorney in Fact)
2017-05-23